Edward G Maliski
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$3.1MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 5, 2026 | NIH | SBIR Phase II Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS) | $899K | OAK THERAPEUTICS INC |
| Jul 28, 2026 | NIH | SBIR Phase II Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis | $814K | OAK THERAPEUTICS INC |
| Aug 14, 2025 | NIH | SBIR Phase II Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis | $893K | OAK THERAPEUTICS INC |
| Aug 25, 2023 | NIH | SBIR Phase I Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis | $273K | OAK THERAPEUTICS INC |
| Aug 26, 2022 | NIH | SBIR Phase I Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS) | $217K | OAK THERAPEUTICS INC |
Peer ranks
Federal funding#632
Awards as PI#470
Patents#505
Companies
- OAK THERAPEUTICS INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.